Please assess the completion status of the following clinical trial:

Trial Title: TRAUMEEL for Pain After Total Knee/Hip Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients of either sex undergoing unilateral THAP or TKAP.~* Age over 18 years.~* Signature upon informed consent form~Exclusion Criteria:~* Participation in another clinical trial within 4 weeks prior to enrollment.~* Refused to give verbal consent to the telephone interviews~* Impossibility to be reached during the 14-17 days post operative~* Inability to comply with the study protocol for any other reason~* Previous major surgical procedure on ipsilateral leg.~* Current use of analgesics for any other reason.~* A history of chronic pain syndrome.~* Abused legal or illicit drug use.~* Hypersensitivity to botanicals of the Compositae family~* Known sensitivity to paracetamol, codeine or tramadol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): TraumeelS
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).